Nana Ninagawa-Takenaka
Nagoya, 4678601, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Distinct muscle regenerative capacity of human induced pluripotent stem cell-derived mesenchymal stromal cells in Ullrich congenital muscular dystrophy model mice.
Journal: Stem cell research & therapy
Published: July 17, 2024
Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance.
Journal: Stem cell research & therapy
Published: December 18, 2023
Dissociation of SH3 and cysteine-rich domain 3 and junctophilin 1 from dihydropyridine receptor in dystrophin-deficient muscles.
Journal: American journal of physiology. Cell physiology
Published: August 01, 2022
Systemic Supplementation of Collagen VI by Neonatal Transplantation of iPSC-Derived MSCs Improves Histological Phenotype and Function of Col6-Deficient Model Mice.
Journal: Frontiers in cell and developmental biology
Published: October 06, 2021
Collagen-VI supplementation by cell transplantation improves muscle regeneration in Ullrich congenital muscular dystrophy model mice.
Journal: Stem cell research & therapy
Published: May 06, 2021
Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineage.
Journal: NPJ Regenerative medicine
Published: April 29, 2021
Acute and temporal expression of tumor necrosis factor (TNF)-α-stimulated gene 6 product, TSG6, in mesenchymal stem cells creates microenvironments required for their successful transplantation into muscle tissue.
Journal: The Journal of biological chemistry
Published: December 04, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026